Non-pegylated Liposomal Doxorubicin as Palliative Chemotherapy in pre-Treated Advanced Pancreatic Cancer: A Retrospective Analysis of Twenty-Eight Patients.

Konstantin Schlick* (First author), Dominik Kiem (Co-author), Florian Huemer (Co-author), Daniel Neureiter (Co-author), Lukas Weiss (Co-author), Richard Greil (Last author)

*Corresponding author for this work

Research output: Contribution to journalOriginal Articlepeer-review

6 Citations (Web of Science)
Original languageEnglish
Pages (from-to)15330338211042139
JournalTECHNOLOGY IN CANCER RESEARCH & TREATMENT
Volume20
DOIs
Publication statusPublished - 2021

Keywords

  • OPEN-LABEL
  • PHASE-II
  • STROMA
  • EPIDEMIOLOGY
  • TOLERABILITY
  • GEMCITABINE
  • FOLFIRINOX
  • RATIONALE
  • DIAGNOSIS
  • SURVIVAL

Cite this